Efficacy and Safety of Angong Niuhuang Wan for Stroke

Summary

To evaluate the efficacy and safety of using Chinese Medicine Angong Niuhuang Wan in stroke patients, the modified Rankin Scale (mRS) score will be used as primary outcome, the National Institutes of Health Stroke Scale (NIHSS) score, The Modified Barthel Index (MBI) score and the Montreal Cognitive Assessment (MoCA) scores will be used as secondary outcome measures.

Timeline

Start

2019-10-15

Primary completion

2022-12-30

Completion

2023-06-30

Drugs

Indications